Newsroom

Newsroom
May 18
MRIGlobal Honors William A. (Bill) Hall

William A. (Bill) Hall named Life Trustee for Commitment, Long-term Service to MRIGlobal

Kansas City, Mo. – MRIGlobal announced that William A. (Bill) Hall has been honored as an MRIGlobal Life Trustee

The announcement was made today at the mid-year meeting of the MRIGlobal Board of Trustees and Directors. Mr. Hall was thanked for his exceptional contributions and his long-term service to MRIGlobal.

In addition to more than 29 years as an MRIGlobal Trustee, Mr. Hall served nine years as a Director on the Board and four years as Board Chair.

"MRIGlobal is indebted to Bill Hall for his unwavering leadership over nearly three decades of service," said Thomas M. Sack, Ph.D., MRIGlobal President and CEO. "As our ambassadors to the community, the Trustees and Board are vital to our business. Bill truly deserves this honor for his stalwart efforts."

In MRIGlobal's 73 year history, Hall is the 13th person to be recognized as a Life Trustee.

Mr. Hall is assistant to the chairman and a corporate officer at Hallmark Cards, Inc. He is president of the Hall Family Foundation, a private philanthropic organization dedicated to enriching the Kansas City community.

Mr. Hall joined Hallmark in 1968 upon graduating from Southern Methodist University with a master's degree in finance. He performed various financial duties for Hallmark before being named manager of Investment Properties for the company in 1973. In 1976, he was named assistant to the president, as well as treasurer of The Hallmark Educational Foundations, the forerunner of today's Hall Family Foundation. He became president of the Hall Family Foundation in 1982.

In addition to his service to MRIGlobal, Mr. Hall serves on the Boards of Directors for The National Museum of Toys and Miniatures, University of Kansas Cancer Advisory Board, H&R Block Foundation, Marion and Henry Bloch Family Foundation, National Association of Basketball Coaches Foundation and University of Kansas Hall Center for the Humanities.

Mr. Hall's fellow MRIGlobal Life Trustees include: Charles W. Battey; Henry W. Bloch; Richard Green, Jr.; Donald J. Hall; Irvine O. Hockaday, Jr.; A. Drue Jennings; Robert A. Kipp; Louis W. Smith; Morton I. Sosland; and the late David M. Clark, S.J.; George C. Dillon; Charles H. Price, II.


May 18
MRIGlobal Adds New Trustees

Tim Petty, Kansas City Market President, US Bank of Kansas City; Ronald A. Sleptiza, Ph.D., President, Avila University; Danette Wilson, CEO and President, Blue Cross and Blue Shield of Kansas City

New Trustees bring key expertise in banking, education, business

Kansas City, Mo. – MRIGlobal announced that its Board of Directors has elected three new members to the MRIGlobal Board of Trustees.

The three newly appointed trustees are:

  • Tim Petty, Kansas City Market President, US Bank of Kansas City
  • Ronald A. Slepitza, Ph.D., President, Avila University
  • Danette Wilson, CEO and President, Blue Cross and Blue Shield of Kansas City

MRIGlobal trustees serve as ambassadors to the community to advocate our efforts in making the world safer, healthier, and more sustainable.

MRIGlobal's Board of Directors govern and direct the leadership of the organization while the 127 members of the Board of Trustees serve in an advisory capacity to the Board of Directors.

May 01
MRIGlobal to Support Pre-Clinical Drug Development and Manufacture for National Institutes of Health National Center for Advancing Translational Sciences (NCATS)

Within NCATS, MRIGlobal Awarded "CRO Support for NCATS Drug Substance and Development"

Kansas City, Mo. – MRIGlobal today announced the award of a five-year year program from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS). The Program will support the Division of Pre-Clinical Innovation (DPI) efforts for pre-clinical drug development.

Within NCATS, the DPI plans and conducts advanced collaborative research projects across the pre-clinical phases of translational science.

MRIGlobal will supply services related to synthesis and analysis of small molecules, and will provide support for manufacture and analysis of small molecules; process chemistry optimization; API (active pharmaceutical ingredients) characterization; analytical method validation; and controlled stability studies.

"MRIGlobal is honored to continue our support of the important work within NCATS to develop new therapies," said Thomas M. Sack, Ph.D., President and Chief Executive Officer. "We anticipate task orders this fall."  

This project is funded in whole or in part with Federal funds from the National Center for Advancing Translational Sciences at the National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN271201700006I; Ref. No. N01TR-17-2201.

Apr 20
CBCS Deployed in Largest International Biocontainment Evacuation Exercise in History ‘Tranquil Shift’


MRIGlobal_CBCS_medevac.jpgMRIGlobal’s CBCS units (view brochure) deployed in ‘Tranquil Shift’

The international exercise described by U.S. officials as “the largest overseas biocontainment exercise in history” was an interagency task force led by the U.S. Department of State’s director of Operational Medicine and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response.

‘Tranquil Shift’ assessed the readiness of federal, state, local, and private partners to respond to an outbreak overseas by testing the U.S. Government’s maximum lift capability in response to a simulated outbreak of a highly contagious pathogen.

MRIGlobal’s CBCS Containerized BioContainment Systems were used to evacuate simulated American patients to Ebola treatment centers across the United States.

On April 11th, a total of five aircraft – two 747s and three Gulfstream IIIs – departed Atlanta, Georgia, traveled to Dakar, Senegal, where they prepared for the evacuation.

On April 12th, all these aircraft flew to Freetown, Sierra Leone to pick up their patients and flew on to Washington Dulles Airport to clear customs.

Read the official debrief: April 19, 2017

Mar 22
MRIGlobal to Provide Broad Range of Support to the U.S. Department of Defense Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD)

A key task under the Homeland Defense Technical Area Tasks contract awarded to MRIGlobal will provide innovative work in chemical and biological defense.

Kansas City, Mo. – MRIGlobal was awarded the Research, Development, Test and Evaluation, and Strategic Initiatives task under the Homeland Defense Technical Area Tasks (HD TAT) contract with DTIC on 10 February 2017.

MRIGlobal will provide a broad range of technical services to the defense community to study, analyze, advise, research, and develop deliverables to advance Homeland Defense (HD) related scientific and technical information (STI).

The contract is intended to provide defense researchers and acquisitions teams with access to leading capabilities and experts in Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) defense areas.

"The projects we'll conduct on this task build upon our more than 70 years of expertise supporting our Nation's vital functions protecting us from the continuing CBRNE threat" said Thomas M. Sack, Ph.D., President and Chief Executive Officer, MRIGlobal. "We are excited to begin this new chapter in our work to serve our defense community."

"We have some of the best staff and facilities in the world" said Robert Conklin, Vice-President for Technical Operations, MRIGlobal. "This contract allows us to continue to provide these services to the entire Defense Enterprise."

Mar 22
MRIGlobal Supports BARDA with Development of Medical Countermeasures for Biological Threats

Biomedical Advanced Research and Development Authority (BARDA)Continues Relationship with MRIGlobal in Nonclincial Studies Network

Kansas City, Mo. – MRIGlobal will continue its relationship with the Biomedical Advanced Research and Development Authority (BARDA) in its mission to support development and acquisition of medical countermeasures to prevent or treat biological threats, pandemic influenza, and emerging infectious diseases.

BARDA's Nonclinical Studies Network (NSN) is a key element in the successful development of medical countermeasures for biological threats.

"We are very pleased to mark seven years as a member of BARDA's Nonclinical Studies Network," said Thomas M. Sack, Ph.D., President and Chief Executive Officer. "We look forward to our continued collaboration."

MRIGlobal will support BARDA's mission by completing studies regulated under the Good Laboratory Practices (GLP) regulations as well as other unregulated studies which will support the advancement of potential life-saving therapeutics and vaccines.

About BARDA

The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.

The mission of BARDA is to develop and procure medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases. Specifically, BARDA supports the advanced development and procurement of drugs, vaccines and other products that are considered priorities for national health security through its programmatic initiatives.

Mar 22
MRIGlobal Supports Hispanic Organization of Toxicologists

Jose Zavala, Ph.D., Wins Travel Scholarship to Present Research at Conference.

JoseZavalaScholarship.jpgMRIGlobal is proud to announce the winner of its travel award to attend the annual conference of the Society of Toxicology (SOT) Conference in Baltimore.

Jose Zavala, Ph.D., is performing his post doctorate research training work at the U.S. Environmental Protection Agency.

At the conference, Dr. Zavala presented his research, "Gas-phase mutagenicity in salmonella of 12 distinct simulated smog atmospheres generated using environmental irradiation chambers."

Dr. Zavala was introduced at a special Hispanic Organization of Toxicologists event by Robert P. Casillas, Ph.D., Vice President, Strategic Global Health Security, MRIGlobal.

The travel award was presented March 14 at the Hispanic Organization Annual Reception at the conference.

The SOT 56th Annual Meeting and ToxExpo, held March 12-16, 2017, is the world's largest forum to showcase discoveries and achievements in toxicology research. More than 6,800 of the world's leading researchers and scientists and toxicologists from academia, government, and industry participate in lectures, training, and scientific sessions.

Feb 17
MRIGlobal Hosts Open House For Paseo’s First Robotics Team

Public event will showcase Paseo/MRIGlobal's 11th FIRST Robotics season.

Kansas City, Mo. – MRIGlobal will host an open house from 3 to 5 p.m. on Monday, February 20, 2017, for the FIRST robotics team from Paseo Academy of Fine and Performing Arts. The event will take place in the MRIGlobal Mag Auditorium, 4920 Cherry St.

This is the eleventh year MRIGlobal has sponsored, mentored, and coached Paseo Academy's FIRST Robotics program.

Monday's event is free and open to the public. Parking is available at the auditorium, which is on the grounds of the MRIGlobal headquarters.

Paseo's robot will compete in the FIRST Regional Robotics Competition March 17-18 at Metropolitan Community College Business and Technology Center, 1775 Universal Avenue, Kansas City, Missouri. The competition is free to attend.

FIRST Robotics was launched by inventor and founder, Dean Kamen.


Feb 14
MRIGlobal Named Kansas City’s Healthiest Employer

MRIGlobal awarded top prize at Feb. 9 event.

Kansas City, Mo. – MRIGlobal was named Healthiest Employer in Kansas City Business Journal's Healthiest Employers competition (100-499 category).

MRIGlobal offers staff on-site wellness coaching, wellness room, nutrition programs, and dozens of programs each year. In 2016, the wellness room was remodeled to include a massage area and the recreation room was added to accommodate playing darts or pingpong.

For decades, MRIGlobal has maintained an on-site gym with an indoor basketball court, an array of fitness equipment, weights, and locker rooms. Outside, there are facilities for sand volleyball and touch football, plus a terraced amphitheater and access to great running/walking trails. During lunch and before and after work, MRIGlobal provides employees and their families with many types of free fitness classes.

This year, 22 companies with local offices made the finalist cut, based on wellness programming and benefits.

Competing employers were split into categories by global workforce size. Healthiest Employers LLC, a data research company, measured those factors. The assessment scored organizations on the wellness program's culture and leadership commitment, foundational components, strategic planning, communication and marketing, programming and interventions, and reporting and analysis.

Feb 06
MRIGlobal Presents “The Role Of Genomics in Emerging Infectious Disease Surveillance” at American Society for Microbiology (ASM) Biothreats Conference

ASM BIOTHREATS: Research, Response, and Policy Conference is Feb. 6-8 in Washington, D.C.

Kansas City, Mo. – MRIGlobal will present an interactive session entitled, "The Role of Genomics in Emerging Infectious Disease Surveillance" at the 2017 ASM Biothreats: Research, Response, and Policy meeting on February 7 in Washington, D.C.

Moderated by MRIGlobal Chief Science Advisor, Chris Detter, Ph.D., the session features experts in One Health Surveillance approaches and practice; science and technology (pathogen genomics and bioinformatics); and regulatory compliance and public health policy implications of pathogen genomics.

MRIGlobal will also showcase technical poster presentations:

  • Ultraportable Technologies for OnSite Arbovirus Surveillance from Mosquitos: Bringing the Lab to the Sample
  • Development and Implementation of Ebola Virus Disease Diagnostics Training in West Africa

The meeting runs from February 6-8 and was formerly known as the ASM Biodefense and Emerging Diseases Research Meeting. The 2017 ASM Biothreats: Research, Response, and Policy meeting is sponsored by the American Society for Microbiology. Held at Marriott Wardman Park, the conference will discuss a wide range of biological threats and emerging infectious diseases to stimulate knowledge-sharing amongst stakeholders in academia, industry and government and help the overlapping communities prepare for, mitigate, and prevent these global threats. The event covers relevant topics in basic and applied research; public health, emergency response and preparedness; and biosecurity, government, and policy responses.
 
About the American Society for Microbiology
The American Society for Microbiology (ASM) is the largest single life science society, composed of over 47,000 scientists and health professionals. ASM's mission is to promote and advance the microbial sciences.

ASM advanced the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of microbial sciences to diverse audiences.


1 - 10Next

 ‭(Hidden)‬ Blog Tools

​​​DefenseEnegryHealth

 Media Inquiries

Pamela Sharitz-Tesch
External Communication Manager
(816) 360-1968

 Blog Notifications